Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 6 open reading frame 136 (C6orf136) is a poorly characterized human protein encoded by the C6orf136 gene and contains a conserved DUF2358 domain of unknown function.[1] The gene is broadly expressed, including in heart, intestine, brain, and kidney, and its protein is predicted to localize to the nucleus in humans.[1] The molecular function of C6orf136 remains unelucidated, but studies indicate it may play a role in cancer, especially as a target for FOXM1-induced hypermethylation in head and neck squamous cell carcinoma, and as a prognostic biomarker in bladder cancer through its involvement in self-renewal, migration, and invasion of cancer stem cells.[1][2][3] There are no known drugs targeting C6orf136, and no established mechanisms of action for modulators, reflecting its status as an uncharacterized or research-stage molecular entity rather than a validated therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 6 open reading frame 136 (C6orf136).